<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-5552</journal-id>
<journal-title><![CDATA[Revista Salud Uninorte]]></journal-title>
<abbrev-journal-title><![CDATA[Salud, Barranquilla]]></abbrev-journal-title>
<issn>0120-5552</issn>
<publisher>
<publisher-name><![CDATA[Fundación Universidad del Norte, División de Ciencias de la]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-55522022000100159</article-id>
<article-id pub-id-type="doi">10.14482/sun.38.1.618.361</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Niveles de homocisteína y factores de riesgo asociados con preeclampsia en gestantes de Santa Marta y Barranquilla (Colombia)]]></article-title>
<article-title xml:lang="en"><![CDATA[Levels of homocysteine and risk factors associated with preeclampsia in pregnant women of Santa Marta and Barranquilla (Colombia)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[HERNÁNDEZ AGUIRRE]]></surname>
<given-names><![CDATA[ENIO]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[PEÑUELA GUERRERO]]></surname>
<given-names><![CDATA[NURYS]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[VLECK]]></surname>
<given-names><![CDATA[MARY VAN]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[ARRIETA DE CASTRO]]></surname>
<given-names><![CDATA[FRANCISCA]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Cooperativa de Colombia Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Santa Marta ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Cooperativa de Colombia  ]]></institution>
<addr-line><![CDATA[Santa Marta ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Seton Catholic Central  ]]></institution>
<addr-line><![CDATA[New York ]]></addr-line>
<country>E.U.A</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Fundación FUSORI  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<volume>38</volume>
<numero>1</numero>
<fpage>159</fpage>
<lpage>175</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-55522022000100159&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-55522022000100159&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-55522022000100159&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Fundamentos y objetivo: La preeclampsia o hipertensión arterial gestacional es una complicación del embarazo y en su etiología intervienen factores genéticos, metabólicos y ambientales. Globalmente ocurre en el 3-10 % de los embarazos, y en Colombia produce muerte materna en el 5-7 % de los embarazos. Entre las causas que favorecen su desarrollo se encuentra el estrés oxidativo generado por elevados niveles de homocisteína. El objetivo de este estudio fue establecer la relación de los niveles de homocisteína y otros factores entre gestantes con preeclampsia y sin preeclampsia en el tercer trimestre de la gestación.  Método: En una población de 47 gestantes sin preeclampsia y 41 gestantes con preeclampsia se realizó una encuesta con consentimiento informado y la medición de homocisteína plasmática mediante inmunoensayo de fluorescencia polarizada en un analizador IMx-System. La edad gestacional se determinó mediante ecografía; la tensión arterial y peso materno de la historia clínica. El análisis estadístico abarcó la prueba de Kruskal-Wallis, tablas de contingencia 2x2, Chi cuadrado de Pearson y análisis multivariado, utilizando el paquete estadístico SPSS 17.  Resultados: Se encontró diferencias significativas en los niveles de homocisteína entre casos y controles. Hubo correlación entre homocisteína con el índice de masa corporal y presión arterial. Se encontró que la hiperhomocisteinemia representa un riesgo para preeclampsia significativamente mayor en el grupo con antecedentes familiares en comparación con el grupo sin antecedentes.  Conclusiones: En la población estudiada, la hiperhomocisteinemia, el índice de masa corporal y los antecedentes familiares de preeclampsia representan factores de riesgo para esta patología.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Fundamentals and objective: Preeclampsia, or gestational hypertension, is the most common complication of pregnancy. The etiology is affected by genetic, metabolic, and environmental factors. It occurs globally in 3-10% of pregnancies, and in Colombia it is an important cause of maternal death, occurring in 5-7 % of all pregnancies. Oxidative stress generated by high levels of homocysteine is one of the causes that contribute to the development of this complication. The objective of the present study was to establish the relationship of homocysteine levels and other factors between pregnant women with pre-eclampsia and without pre-eclampsia.  Method: In a population of 47 pregnant women without pre-eclampsia and 41 pregnant women with pre-eclampsia, a survey with informed consent and measurement of plasma homocysteine that was performed by polarized fluorescence immunoassay using an IMx-System analyzer. The gestational age was determined by obstetric ultrasound and the blood pressure and weight data of the clinical history. In the statistical analysis, the Kruskal-Wallis test, 2x2 contingency tables, Pearson's Chi square and multivariate analysis were performed, using the SPSS 17 statistical package.  Results: Significant differences were found between homocysteine values between cases and controls. There was a correlation between homocysteine values, body mass index, and blood pressure. It was also found that hyper-homocysteinemia represents a significantly higher risk of preeclampsia in the group with a family history, compared to the group with no history.  Conclusions: In our population, hyper-homocysteinemia, body mass index, and family history of preeclampsia represent risk factors for this pathology.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hipertensión gestacional]]></kwd>
<kwd lng="es"><![CDATA[homocisteína]]></kwd>
<kwd lng="es"><![CDATA[índice de masa corporal]]></kwd>
<kwd lng="es"><![CDATA[presión arterial]]></kwd>
<kwd lng="en"><![CDATA[gestational hypertension]]></kwd>
<kwd lng="en"><![CDATA[homocysteine]]></kwd>
<kwd lng="en"><![CDATA[body mass index]]></kwd>
<kwd lng="en"><![CDATA[blood pressure]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Zamora]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Tassies]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Carmona]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cervera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Reverter]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Balasch]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies]]></article-title>
<source><![CDATA[J Reprod Immunol]]></source>
<year>2010</year>
<volume>86</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>133-40</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ducloy-Bouthors]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clotting disorders and preeclampsia]]></article-title>
<source><![CDATA[Ann Fr Anesth Reanim]]></source>
<year>2010</year>
<numero>29</numero>
<issue>29</issue>
<page-range>e121-34</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kozic]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Benton]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hutcheon]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Payne]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Magee]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Dadelszen]]></surname>
<given-names><![CDATA[Von]]></given-names>
</name>
</person-group>
<source><![CDATA[J Obstet Gynaecol Can]]></source>
<year>2011</year>
<volume>33</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>995-1004</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Basu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Centola]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jenkins]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum Inflammatory Markers and Preeclampsia in Type 1 Diabetes: A prospective study]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2013</year>
<volume>36</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2054-61</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alaupovic]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jenkins]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Nankervis]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2012</year>
<volume>97</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1752-62</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chelbi]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Vaiman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genetic and epigenetic factors contribute to the onset of preeclampsia]]></article-title>
<source><![CDATA[Mol Cell Endocrinol]]></source>
<year>2008</year>
<volume>282</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>120-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valenzuela]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Sepúlveda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Repetto]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[LLanes]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathogenesis of preeclampsia: the genetic component]]></article-title>
<source><![CDATA[J Pregnancy]]></source>
<year>2012</year>
<volume>2012</volume>
<page-range>632-732</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghulmiyyah]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sibai]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Maternal mortality from preeclampsia/eclampsia]]></article-title>
<source><![CDATA[Semin Perinatol]]></source>
<year>2012</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>56-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chicaíza-Becerra]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[García-Molina]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Oviedo-Ariza]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Urrego-Novoa]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Rincón-Rodríguez]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rubio-Romero]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Costo efectividad del suplemento de calcio para reducir la mortalidad materna asociada a preeclampsia en Colombia]]></article-title>
<source><![CDATA[Rev. Salud Pública]]></source>
<year>2016</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>300-10</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robillard]]></surname>
<given-names><![CDATA[PY]]></given-names>
</name>
<name>
<surname><![CDATA[Dekker]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chaouat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hulsey]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Saftlas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiological studies on primipaternity and immunology in preeclampsia-a statement after twelve years of workshops]]></article-title>
<source><![CDATA[J Reprod Immunol]]></source>
<year>2011</year>
<numero>89</numero>
<issue>89</issue>
<page-range>104-17</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gálvez-Vengoechea M]]></surname>
<given-names><![CDATA[Arreaza-Graterol M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Ortiz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortalidad materna de pacientes atendidas en la uci del hospital simón bolívar, Bogotá (Colombia) 2004 - 2006]]></article-title>
<source><![CDATA[Revista Colombiana de Obstetricia y Ginecología]]></source>
<year>2009</year>
<volume>60</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>152-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dusse]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Nessralla Alpoin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lwaleed]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[De Sousa]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
<name>
<surname><![CDATA[Das Gracas Carvalho]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bragas Gómez]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is there a link between endothelial dysfunction, coagulation activation and nitric oxide synthesis in preeclampsia?]]></article-title>
<source><![CDATA[Clin Chim Acta]]></source>
<year>2013</year>
<volume>415</volume>
<page-range>226-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jobe]]></surname>
<given-names><![CDATA[SO]]></given-names>
</name>
<name>
<surname><![CDATA[Tyler]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Magness]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction]]></article-title>
<source><![CDATA[Hypertension]]></source>
<year>2013</year>
<volume>61</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>480-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scholten]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Hopman]]></surname>
<given-names><![CDATA[HT]]></given-names>
</name>
<name>
<surname><![CDATA[Sweep]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Van de Vlught]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Van Dijk]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Oven]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Co-occurrence of cardiovascular and prothrombotic risk factors in women with a history of preeclampsia]]></article-title>
<source><![CDATA[Obstet Gyne-col]]></source>
<year>2013</year>
<volume>121</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>97-105</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laskowska]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Laskowska]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Terbash]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Oleszczuk]]></surname>
<given-names><![CDATA[Jan]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[JA comparasion of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine and homocisteine in normal and preeclamptic pregnancies]]></article-title>
<source><![CDATA[Med Sci Monit]]></source>
<year>2013</year>
<numero>19</numero>
<issue>19</issue>
<page-range>430-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guven]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Coskun]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ertas]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Aral]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zencirci]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Oksuz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight]]></article-title>
<source><![CDATA[Hypertens Pregnancy]]></source>
<year>2009</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>190-200</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khosrowbeygi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmadvand]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Positive correlation between serum levels of adiponectin and homocysteine in pre-eclampsia]]></article-title>
<source><![CDATA[J Obstet Gynaecol Res]]></source>
<year>2012</year>
<volume>39</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Cui]]></surname>
<given-names><![CDATA[ZL]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[XP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Homocysteine, folate, vitamin B12 and B6 in mothers of children with neural tube defects in Xinjiang, China]]></article-title>
<source><![CDATA[Acta Paediatr]]></source>
<year>2012</year>
<numero>101</numero>
<issue>101</issue>
<page-range>e486-90</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perna A]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ingrosso]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lombardi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Acanfora]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Satta]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Casare]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Possible mechanisms of homocysteine toxicity]]></article-title>
<source><![CDATA[Kidney Int Suppl]]></source>
<year>2003</year>
<volume>84</volume>
<page-range>S137-40</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Selhub]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jacques]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[IH]]></given-names>
</name>
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bowman]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Gunter]]></surname>
<given-names><![CDATA[EW]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum total Homocysteine concentrations in the third National health and nutrition examination survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentration]]></article-title>
<source><![CDATA[Annals of internal Medicine]]></source>
<year>1999</year>
<volume>131</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>331-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braekke]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Veland]]></surname>
<given-names><![CDATA[PM.]]></given-names>
</name>
<name>
<surname><![CDATA[Harsen]]></surname>
<given-names><![CDATA[NK.]]></given-names>
</name>
<name>
<surname><![CDATA[Karlsen]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Blomhoff]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Staff]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Homocysteine, Cysteine, and Related Metabolites in Maternal and Fetal Plasma in Preeclampsia]]></article-title>
<source><![CDATA[Pediatr Res]]></source>
<year>2007</year>
<volume>62</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>319-24</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mujawar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Patil]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Daver]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Study of Serum Homocysteine, Folic Acid and Vitamin B12 in Patients with Preeclampsia]]></article-title>
<source><![CDATA[Ind J Clin Biochem]]></source>
<year>2011</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>257-60</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for preeclampsia in women from Colombia: a case-control study]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[S l]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ospina B]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aroca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2012</year>
<volume>7</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bodnar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Patrick]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Powers]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of obesity in preeclampsia]]></article-title>
<source><![CDATA[Pregnan Hypertens: Int J Women's Cardiovascular Health]]></source>
<year>2011</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-16</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ouyang]]></surname>
<given-names><![CDATA[YQ]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Cai]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[HP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interactions between inflammatory and oxidative stress in preeclampsia]]></article-title>
<source><![CDATA[Hypertens Pregnancy]]></source>
<year>2009</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>56-62</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xiao]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Yin Y]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Gao Y]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia]]></article-title>
<source><![CDATA[Cytokine]]></source>
<year>2012</year>
<volume>60</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>856-60</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molvarec]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rigo]]></surname>
<given-names><![CDATA[JJr]]></given-names>
</name>
<name>
<surname><![CDATA[Lazar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Balogh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mako]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cervenak]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia]]></article-title>
<source><![CDATA[Cell Stress Chaperones]]></source>
<year>2009</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>151-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ibrahim]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Metawie]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[El-Baz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[El-Bahie]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methylenetetrahydrofolate C677T polymorphism and pre-eclamptic Egyptian women]]></article-title>
<source><![CDATA[Mid East Fert Soc J.]]></source>
<year>2012</year>
<numero>17</numero>
<issue>17</issue>
<page-range>05-110</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canto]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Canto-Cetina]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Juarez-Velasquez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rosas-Vargas]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rangel-Villalobos]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Canizales-Quintero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methylenetetrahydrofolate Reductase C677T and Glutathione S-Transferase P1 A313G Are Associated with a Reduced Risk of Preeclampsia in Maya-Mestizo Women]]></article-title>
<source><![CDATA[Hypertens Res]]></source>
<year>2008</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1015-9</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Casas]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Paez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mesa]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Cifuentes]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endothelial NO Synthase Genotype and Risk of Preeclampsia A Multicenter Case-Control Study]]></article-title>
<source><![CDATA[Hypertension]]></source>
<year>2004</year>
<volume>44</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>702-7</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Choudhury]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Friedman]]></surname>
<given-names><![CDATA[J.E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epigenetics and microRNAs in preeclampsia]]></article-title>
<source><![CDATA[Clin Exp Hypertens]]></source>
<year>2012</year>
<volume>34</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>334-41</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kamrani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alipourfard]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmadi-Khiavi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Yousefi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rostamzadeh]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Izadi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmadi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of epigenetic changes in preeclampsia]]></article-title>
<source><![CDATA[Biofactors]]></source>
<year>2019</year>
<volume>45</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>712-24</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gebara]]></surname>
<given-names><![CDATA[Natalia]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Angiogenic Properties of Placenta-Derived Extracellular Vesicles in Normal Pregnancy and in Preeclampsia]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Correia]]></surname>
<given-names><![CDATA[Yolanda]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Keqing]]></given-names>
</name>
<name>
<surname><![CDATA[Bussolati]]></surname>
<given-names><![CDATA[Benedetta]]></given-names>
</name>
</person-group>
<source><![CDATA[Int. J. Mol. Sci]]></source>
<year>2021</year>
<numero>22</numero>
<issue>22</issue>
<page-range>5402</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
